|
Malignant neoplasm of breast
|
0.320 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
|
Malignant neoplasm of prostate
|
0.190 |
AlteredExpression
|
disease |
BEFREE |
KLK15 up-regulation was found to be associated with more aggressive forms of prostate cancer.
|
11010966 |
2001 |
|
Prostate carcinoma
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
KLK15 up-regulation was found to be associated with more aggressive forms of prostate cancer.
|
11010966 |
2001 |
|
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
KLK15 expression tended to be higher in grade 3 than in grade 2 tumors and in Gleason score 7 or greater than in Gleason score less than 7 tumors (p = 0.18 and 0.23, respectively).
|
12478190 |
2003 |
|
ovarian neoplasm
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
KLK15 expression, as assessed by quantitative RT-PCR, is an independent marker of unfavorable prognosis for ovarian cancer.
|
12915603 |
2003 |
|
Malignant neoplasm of ovary
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
KLK15 expression, as assessed by quantitative RT-PCR, is an independent marker of unfavorable prognosis for ovarian cancer.
|
12915603 |
2003 |
|
Prostate Cancer, Hereditary, 7
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
KLK15 SNP rs2659056 was found to be associated with prostate cancer aggressiveness and showed evidence of association in a replication cohort of 5,051 patients from the UK, Australia, and the CGEMS dataset of US samples.
|
22132073 |
2011 |
|
ovarian neoplasm
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.
|
21457553 |
2011 |
|
Malignant neoplasm of ovary
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.
|
21457553 |
2011 |
|
Carcinoma, Ovarian Epithelial
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.
|
21457553 |
2011 |
|
Malignant neoplasm of prostate
|
0.190 |
Biomarker
|
disease |
BEFREE |
As KLK15 has mainly been associated with prostate cancer, we used a degradomic approach and subsequent KEGG pathway analysis to identify a number of putative protein substrates in the KLK15-treated prostate cancer cell line PC3.
|
29928903 |
2018 |
|
Prostate carcinoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
As KLK15 has mainly been associated with prostate cancer, we used a degradomic approach and subsequent KEGG pathway analysis to identify a number of putative protein substrates in the KLK15-treated prostate cancer cell line PC3.
|
29928903 |
2018 |
|
Wheezing
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Further study of this instrument and wheeze in new samples of patients with ACO is warranted.
|
31151458 |
2019 |
|
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Furthermore, KLK15 transcripts were found to be highly expressed in more aggressive tumors (P = 0.017).
|
20067463 |
2010 |
|
Chronic Kidney Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Furthermore, the D-ACO algorithm is tested using benchmark CKD dataset and the performance are investigated based on different evaluation factors.
|
31270387 |
2019 |
|
Bipolar Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Genetic analyses showed that IDH genes (IDH1, IDH2, IDH3A, IDH3B) and ACO genes (ACO1, ACO2) were not associated with BD.
|
26782057 |
2016 |
|
Multiple Chronic Conditions
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
High-risk patients, with high utilisation and multiple chronic illnesses, were identified in the Medicaid ACO population managed by the UofU Health plans for IOC eligibility.
|
30782742 |
2019 |
|
Adenocarcinoma of prostate
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Immunohistochemical expression of the KLK15 protein in 193 samples of prostatic adenocarcinoma was analysed in relation to clinicopathological parameters of the patients and disease progression.
|
20473923 |
2010 |
|
Malignant neoplasm of prostate
|
0.190 |
Biomarker
|
disease |
BEFREE |
In search of biomarkers for prostate cancer, we evaluated the expression of the human kallikrein-related peptidase KLK15 in samples of prostatic adenocarcinomas from radical prostatectomies.
|
20473923 |
2010 |
|
Prostate carcinoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
In search of biomarkers for prostate cancer, we evaluated the expression of the human kallikrein-related peptidase KLK15 in samples of prostatic adenocarcinomas from radical prostatectomies.
|
20473923 |
2010 |
|
Adenocarcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
In search of biomarkers for prostate cancer, we evaluated the expression of the human kallikrein-related peptidase KLK15 in samples of prostatic adenocarcinomas from radical prostatectomies.
|
20473923 |
2010 |
|
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
In the past 5 years, the newly discovered kallikreins (KLK4-KLK15) have been associated with several types of cancer.
|
15911097 |
2005 |
|
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
In the past 5 years, the newly discovered kallikreins (KLK4-KLK15) have been associated with several types of cancer.
|
15911097 |
2005 |
|
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Like other kallikreins, KLK15 is regulated by steroid hormones in cancer cell lines.
|
12915603 |
2003 |
|
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
Like other kallikreins, KLK15 is regulated by steroid hormones in cancer cell lines.
|
12915603 |
2003 |